Picture of Anika Therapeutics logo

ANIK Anika Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapHigh Flyer

Brief: Anika Therapeutics Q1 Adjusted Earnings Per Share $0.06

May 6 (Reuters) - Anika Therapeutics Inc  ANIK.O :
    * ANIKA REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS
    * Q1 ADJUSTED EARNINGS PER SHARE $0.06
    * Q1 EARNINGS PER SHARE $0.20
    * Q1 REVENUE ROSE 3 PERCENT TO $34.3 MILLION
    * ON TRACK TO ACHIEVE STATED REVENUE GROWTH IN 2021
    * EXPECTS UPPER 20% TO LOW 30% REVENUE GROWTH IN JOINT
PRESERVATION AND RESTORATION IN FY
    * IN FY SEES LOW SINGLE-DIGIT GROWTH IN JOINT PAIN
MANAGEMENT AND
MID SINGLE-DIGIT DECLINE IN ITS OTHER PRODUCT FAMILY

Source text for Eikon:  ID:nGNX7Cclys 
Further company coverage:  ANIK.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Anika Therapeutics

See all news